Different stimulation conditions affect the immune phenotype of GD2-specific chimeric antigen receptor-expressing T cells

被引：0
|
作者：
Ochs, Laurin
Altvater, Bianca
Kailayangiri, Sareetha
Spurny, Christian
Rossig, Claudia
Jamitzky, Silke
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2314
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2314
引用
收藏
页数：3
相关论文
共 50 条
  • [1] GD2-specific chimeric antigen receptor T cells targeting retinoblastoma
    Sujjitjoon, Jatuporn
    Atchaneeyasakul, La-ong Sri
    Tsao, Shih-Ting
    Sayour, Elias
    Yenchitsomanus, Pa-thai
    Chang, Lung-Ji
    CANCER RESEARCH, 2015, 75
  • [2] Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2
    Gargett, Tessa
    Brown, Michael P.
    CYTOTHERAPY, 2015, 17 (04) : 487 - 495
  • [3] eNovel GD2-specific chimeric antigen receptor-modified T cells targeting osteosarcoma
    Chulanetra, Monrat
    Sayour, Elias
    Eldjerou, Lamis
    Lagmay, Joanne
    Milner, Rowan
    Slayton, William
    Chang, Lung-Ji
    CANCER RESEARCH, 2015, 75
  • [4] Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15
    Tian, Gengwen
    Courtney, Amy N.
    Yu, Hangjin
    Bhar, Saleh
    Xu, Xin
    Barragan, Gabriel A.
    Amador, Claudia Martinez
    Ghatwai, Nisha
    Wood, Michael S.
    Schady, Deborah
    Montalbano, Antonino
    Reddy, Shantan
    Roche, Aoife M.
    de la Cerda, David
    Parsons, Donald Williams
    Di Pierro, Erica J.
    Bushman, Frederic D.
    Heczey, Andras
    Metelitsa, Leonid S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (01)
  • [5] Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15
    Chen, Yuhui
    Sun, Chuang
    Landoni, Elisa
    Metelitsa, Leonid
    Dotti, Gianpietro
    Savoldo, Barbara
    CLINICAL CANCER RESEARCH, 2019, 25 (09) : 2915 - 2924
  • [6] Design and development of therapies using chimeric antigen receptor-expressing T cells
    Dotti, Gianpietro
    Gottschalk, Stephen
    Savoldo, Barbara
    Brenner, Malcolm K.
    IMMUNOLOGICAL REVIEWS, 2014, 257 (01) : 107 - 126
  • [7] GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction
    Sujjitjoon, Jatuporn
    Sayour, Elias
    Tsao, Shih-Ting
    Uiprasertkul, Mongkol
    Sanpakit, Kleebsabai
    Buaboonnam, Jassada
    Yenchitsomanus, Pa-thai
    Atchaneeyasakul, La-ongsri
    Chang, Lung-Ji
    TRANSLATIONAL ONCOLOGY, 2021, 14 (02):
  • [8] BRAF and MEK Inhibition Variably Affect GD2-specific Chimeric Antigen Receptor (CAR) T-Cell Function In Vitro
    Gargett, Tessa
    Fraser, Cara K.
    Dotti, Gianpietro
    Yvon, Eric S.
    Brown, Michael P.
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (01) : 12 - 23
  • [9] GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients
    Lihua Yu
    Lulu Huang
    Danna Lin
    Xiaorong Lai
    Li Wu
    Xu Liao
    Jiale Liu
    Yinghua Zeng
    Lichan Liang
    Guanmei Zhang
    Bin Wang
    Zhu Wu
    Shaohua Tao
    Yuchen Liu
    Cheng Jiao
    Lung-Ji Chang
    Lihua Yang
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2643 - 2652
  • [10] GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients
    Yu, Lihua
    Huang, Lulu
    Lin, Danna
    Lai, Xiaorong
    Wu, Li
    Liao, Xu
    Liu, Jiale
    Zeng, Yinghua
    Liang, Lichan
    Zhang, Guanmei
    Wang, Bin
    Wu, Zhu
    Tao, Shaohua
    Liu, Yuchen
    Jiao, Cheng
    Chang, Lung-Ji
    Yang, Lihua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2643 - 2652
12345